![](/img/cover-not-exists.png)
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Mora, Paulo Alexandre Ribeiro, Sun, Sue Yazaki, Velarde, Guillermo Coca, Filho, Jorge Rezende, Uberti, Elza H., dos Santos Esteves, Ana Paula Vieira, Elias, Kevin M., Horowitz, Neil S., Braga, AntonioLanguage:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.03.005
Date:
March, 2019
File:
PDF, 402 KB
english, 2019